Searched for
NARAYANA HRUDAYALAYA TARGET PRICE
Companies should focus on business growth, profitability rather than just share price: NSE chiefNSE MD and CEO Ashish Chauhan urged companies to prioritize building sustainable businesses and long-term value over solely chasing share p...- NSE chief urges startups and MSMEs to view listing as a tool for scaleNational Stock Exchange MD and CEO Ashish Chauhan highlighted that profitable businesses are rewarded with valuations private markets can't...
- These large-, mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the old saying goes: Nothing can be ruled out on the street. Which means that one should be prepared for anything. Now, what is the prob...
- Eli Lilly launches cancer drug Tanstrive in IndiaThe launch follows marketing authorisation from the Central Drugs Standard Control Organisation (CDSCO) for patients with locally advanced ...
- Nifty headed to 24,500 next week, says Dharmesh Shah; these 2 stocks are top buys right nowIndian equity markets are poised for further gains, with Nifty eyeing 24,500, according to ICICI Direct's Dharmesh Shah. He highlights fall...
- Bengaluru startup Airbound ties up with Andhra Pradesh to build drone delivery networkBengaluru's Airbound is partnering with Andhra Pradesh Drone Corporation to launch a massive drone delivery network in the Amaravati Capita...
- Buy, Sell or Hold: Goldman Sachs maintains sell on Bharat Dynamics; HDFC Securities maintains buy on IndiaMART InterMESHBrokerages remain divided on two stocks. Goldman Sachs retained its 'Sell' rating on Bharat Dynamics, raising the target price marginally t...
- Hot Stocks: 2 stocks that may give returns between 16-19%Leading brokerages CLSA and Morgan Stanley have initiated coverage on Vedanta Aluminium and Adani Enterprises, respectively, signaling sign...
- Stock Radar: Torrent Power stock showing signs of bottoming out after falling 20% from April 2026 highsTorrent Power shares are showing signs of a comeback after a significant dip, with bulls attempting to regain control. Experts suggest a bu...
- Nomura cuts target price of this AI, data centre beneficiary company. Here’s whyNomura remains positive on Anant Raj despite trimming earnings estimates and lowering its target price due to slower cloud ramp-up and proj...
- For investors who focus on the long term: 5 mid-cap stocks from different sectors with upside potential up to 28%When prices fall, caution comes naturally. Investors hesitate, portfolios are reviewed less often, and even optimists become careful. But w...
- Should investors buy the dip in Vedanta shares after 9% slide? Analysts weigh inVedanta shares fell on Tuesday after promoter entity Twin Star Holdings reportedly sold around 7.3 crore shares (1.7% stake) worth ₹2,149 c...
- Sell or Hold: Citi maintains buy on Cipla; Motilal Oswal recommends buy on RIL post AGMBrokerages remain bullish on Cipla and Reliance Industries, citing strong growth drivers and attractive valuations. Citi highlights regulat...
- These large- mid- and small-cap stocks can give more than 25% return in 1 year, according to analystsAs the bulls attempt another serious comeback, the market again faces a familiar question: Are valuations still too high, or have they reac...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- Kiran Mazumdar-Shaw eyes crown of world’s top insulin supplier for BioconIndian drugmaker Biocon aims to be the world's top insulin supplier within five years, capitalising on growing demand as major pharmaceutic...
- The old health insurance model sees hospitalisation as an inconvenience, says Narayana Health's Viren Prasad Shetty; bets on managed care modelIt has been close to two years since Narayana Health’s wholly owned subsidiary, Narayana Health Insurance—which has adopted a ‘managed heal...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- Hospital expansion cycle to keep margins rangebound, but 18 per cent revenue growth trend likely to sustain: Kotak SecuritiesIndian hospitals are set for strong revenue growth. Brokerage firm Kotak Securities predicts double-digit gains. EBITDA margins are expecte...
- Stock Radar: Narayana Hrudayalaya stock breaks out from inverse head & shoulder pattern; time to buy?Narayana Hrudayalaya stock shows a strong bullish breakout. Experts suggest buying for a target above 2,100 levels in the next 1-2 months. ...
Load More
